Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02IQP
|
|||
| Former ID |
DNC013502
|
|||
| Drug Name |
1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one
|
|||
| Synonyms |
CHEMBL402740; SCHEMBL3961770; BDBM50350542; 288862-78-2; 1-(oxazolo[4,5-b]pyridin-2-yl)-1-oxo-pentane
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H12N2O2
|
|||
| Canonical SMILES |
CCCCC(=O)C1=NC2=C(O1)C=CC=N2
|
|||
| InChI |
1S/C11H12N2O2/c1-2-3-5-8(14)11-13-10-9(15-11)6-4-7-12-10/h4,6-7H,2-3,5H2,1H3
|
|||
| InChIKey |
FBFLUTUPSIYUIG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.